Dabigatran specific antidote: new safety level in oral anticoagulation
MMW Fortschritte der Medizin 157(19): 78-79
2015
ISSN/ISBN: 1438-3276 PMID: 26953416 Document Number: 681371
Document emailed within 1 workday
Related Documents
Šlechtová, J.; Hajšmanová, Z.ňka.; Lavičková, A.; Šigutová, P. 2017: The first experience with dabigatran antidote in the University Hospital Pilsen Casopis Lekaru Ceskych 155(8): 442-444Van Gelder, I.C.; Crijns, H.J.; Tieleman, R.G.; Brügemann, J.; De Kam, P.J.; Gosselink, A.T.; Verheugt, F.W.; Lie, K.I. 1996: Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation Archives of Internal Medicine 156(22): 2585-2592
Dieler, R.; Shehata-Dieler, W.E. 1994: Ototoxicity exemplified by aminoglycosides and cisplatin: is there a specific antidote Hno 42(9): 525-528
Okwusidi, J.I.; Alabi, K.I.; Olatunji, L.A.; Oyesola, T.O. 2010: Is hypercalcemic diet a possible antidote to oral contraceptive-induced hypertension? Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria 25(2): 115-119
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Kurlemann, G.; Jorch, G.; Lunkenheimer, A.; Hilgenberg, F. 1985: Treatment of digitalis poisoning with a specific digitalis antidote Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 133(7): 495-496
Hoover, H.C.; Jones, D.; Ketcham, A.S. 1976: The optimal level of anticoagulation for decreasing experimental metastases Surgery 79(6): 625-630
Durán Parrondo, C.; Rodríguez Moreno, C.; Tato Herrero, F.; Alonso Vence, N.; Lado Lado, F.L. 2003: Oral anticoagulation Anales de Medicina Interna 20(7): 377-384
Virjo, I.; Isokoski, M. 1998: Oral anticoagulation therapy Duodecim; Laaketieteellinen Aikakauskirja 114(15): 1518-1519
Avello, A.G.; César, J.; Pardo Vigo, A.; Frade, L.J.; Sánchez Godoy, P.; Navarro, J.L. 1984: Hemorrhage in oral anticoagulation Revista Clinica Espanola 172(6): 315-318
Acar, J. 1993: Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation? Journal of Heart Valve Disease 2(4): 395-397
Rochat, S.; Büla, C. 2005: Oral anticoagulation in elderly people Revue Medicale Suisse 1(39): 2505-2506; 2509-2511
Ikeda, U.; Shimada, K. 2001: Oral anticoagulation therapy during and after coronary angioplasty Circulation 104(24): E150
Loeliger, E.A.; van Dijk-Wierda, C.A. 1977: Therapeutically optimal values in oral anticoagulation Nederlands Tijdschrift Voor Geneeskunde 121(31): 1242-1243
Duckert, F.; Marbet, G.A. 1977: Control of oral anticoagulation--therapeutic range Schweizerische Medizinische Wochenschrift 107(37): 1308
Camp-Wachsmuth, M.; Humair, J.-P.; Boehlen, F. 2009: Advantages of capillary INR monitoring for oral anticoagulation Revue Medicale Suisse 5(218): 1864-1867
Lubetsky, A.; Shasha, Y.; Olchovsky, D.; Loebstein, R.; Halkin, H.; Ezra, D. 2003: Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation Thrombosis and Haemostasis 90(1): 71-76
Murty, J.; Firth, S. 1996: Effect of CSM's warning about safety of third generation oral contraceptives. Contraceptive effectiveness may be being sacrificed for safety Bmj 313(7053): 363
Nuevo González, J.A.; Cano Ballesteros, J.C.; Pintor Holguín, E.; Braun Saro, B.; Visús Soler, E.; Sevillano Fernández, J.A. 2008: Oral anticoagulation excess: analysis from an emergency department Revista Clinica Espanola 208(2): 66-70
Spyropoulos, A.C. 2005: Bridging of oral anticoagulation therapy for invasive procedures Current Hematology Reports 4(5): 405-413